Jahangir Moini
Notes
1- The file is chapter after chapter.
2- We have shown you few pages sample.
3- The file contains all Appendix and Excel
sheet if it exists.
4- We have all what you need, we make
update at every time. There are many new
editions waiting you.
5- If you think you purchased the wrong file
You can contact us at every time, we can
replace it with true one.
Our email:
,Name: Class: Date:
Ch 01 Introduction
1. Which of the following is NOT one of the three main sections of the United States Pharmacopeia?
a. USP 790
b. USP 795
c. USP 797
d. USP 800
ANSWER: a
FEEDBACK: a. Correct. USP 790 is not one of the three main sections of the United States
Pharmacopeia. It was published in 2014, providing needed clarification on what it
means for a parenteral medical product to be "essentially free" of visible
particulate matter.
b. Incorrect. USP 790 is not one of the three main sections of the United States
Pharmacopeia. It was published in 2014, providing needed clarification on what it
means for a parenteral medical product to be "essentially free" of visible
particulate matter.
c. Incorrect. USP 790 is not one of the three main sections of the United States
Pharmacopeia. It was published in 2014, providing needed clarification on what it
means for a parenteral medical product to be "essentially free" of visible
particulate matter.
d. Incorrect. USP 790 is not one of the three main sections of the United States
Pharmacopeia. It was published in 2014, providing needed clarification on what it
means for a parenteral medical product to be "essentially free" of visible
particulate matter.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.1 - Identify the three United States Pharmacopeia (USP) chapters that relate to the various
types of compounding.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 1:41 AM
DATE MODIFIED: 4/4/2023 11:54 PM
2. How many minimum hours of sterile compounding-specific continuing education must be completed during the one-
year renewal period, per the Pharmacy Technician Certification Board?
a. Fifteen hours
b. Ten hours
c. Five hours
d. Two hours
ANSWER: c
FEEDBACK: a. Incorrect. A minimum of five hours of sterile compounding-specific continuing
education must be completed during the one-year renewal period, per the
Pharmacy Technician Certification Board.
b. Incorrect. A minimum of five hours of sterile compounding-specific continuing
education must be completed during the one-year renewal period, per the
Pharmacy Technician Certification Board.
c. Correct. A minimum of five hours of sterile compounding-specific continuing
education must be completed during the one-year renewal period, per the
Pharmacy Technician Certification Board.
Copyright Cengage Learning. Powered by Cognero. Page 1
,Name: Class: Date:
Ch 01 Introduction
d. Incorrect. A minimum of five hours of sterile compounding-specific continuing
education must be completed during the one-year renewal period, per the
Pharmacy Technician Certification Board.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.2 - Describe the two different ways in which a Pharmacy Technician Certification Board
(PTCB)-certified pharmacy technician can qualify to become a Certified Compounded Sterile
Preparation Technician (CSPT).
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 1:59 AM
DATE MODIFIED: 4/4/2023 11:54 PM
3. In the history of sterile compounding, when was laminar airflow introduced?
a. Mid-1950s
b. Mid-1960s
c. Late 1970s
d. Late 1980s
ANSWER: b
FEEDBACK: a. Incorrect. For sterile compounding, laminar airflow was introduced in the mid-
1960s. The first known laminar-airflow hood was used in 1964 in Arkansas as
part of an experimental unit-dose drug distribution system.
b. Correct. For sterile compounding, laminar airflow was introduced in the mid-
1960s. The first known laminar-airflow hood was used in 1964 in Arkansas as
part of an experimental unit-dose drug distribution system.
c. Incorrect. For sterile compounding, laminar airflow was introduced in the mid-
1960s. The first known laminar-airflow hood was used in 1964 in Arkansas as
part of an experimental unit-dose drug distribution system.
d. Incorrect. For sterile compounding, laminar airflow was introduced in the mid-
1960s. The first known laminar-airflow hood was used in 1964 in Arkansas as
part of an experimental unit-dose drug distribution system.
POINTS: 2
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.3 - Identify the hood environments and cleanroom environments that are required in order
for a pharmacy to be USP-compliant in regards to sterile compounding.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:02 AM
DATE MODIFIED: 4/4/2023 11:56 PM
4. "Immediate use" sterile products must be administered within what time period?
a. Two hours
b. Three hours
c. Four hours
d. Eight hours
ANSWER: c
Copyright Cengage Learning. Powered by Cognero. Page 2
,Name: Class: Date:
Ch 01 Introduction
FEEDBACK: a. Incorrect. Immediate use sterile products must be administered within four hours.
These sterile products are for direct, immediate administration and must be
discarded if administration does not begin within four hours of preparation.
b. Incorrect. Immediate use sterile products must be administered within four hours.
These sterile products are for direct, immediate administration and must be
discarded if administration does not begin within four hours of preparation.
c. Correct. Immediate use sterile products must be administered within four hours.
These sterile products are for direct, immediate administration and must be
discarded if administration does not begin within four hours of preparation.
d. Incorrect. Immediate use sterile products must be administered within four hours.
These sterile products are for direct, immediate administration and must be
discarded if administration does not begin within four hours of preparation.
POINTS: 2
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.4 - Summarize the three classifications of compounded sterile preparations.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:03 AM
DATE MODIFIED: 4/4/2023 11:57 PM
5. At what room temperature range must sterile products be stored?
a. 35 to 46°F
b. 46 to 56°F
c. 56 to 67°F
d. 68 to 77°F
ANSWER: d
FEEDBACK: a. Incorrect. A room temperature range of 68 to 77°F is used for the storage of
sterile products. This is part of Category 1 and 2 guidelines for the three different
classifications of compounded sterile products.
b. Incorrect. A room temperature range of 68 to 77°F is used for the storage of
sterile products. This is part of Category 1 and 2 guidelines for the three different
classifications of compounded sterile products.
c. Incorrect. A room temperature range of 68 to 77°F is used for the storage of
sterile products. This is part of Category 1 and 2 guidelines for the three different
classifications of compounded sterile products.
d. Correct. A room temperature range of 68 to 77°F is used for the storage of sterile
products. This is part of Category 1 and 2 guidelines for the three different
classifications of compounded sterile products.
POINTS: 2
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.4 - Summarize the three classifications of compounded sterile preparations.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:05 AM
DATE MODIFIED: 4/4/2023 11:58 PM
6. The most important areas of hospital pharmacy compounding are regulated by which of the following organizations?
Copyright Cengage Learning. Powered by Cognero. Page 3
,Name: Class: Date:
Ch 01 Introduction
a. Food and Drug Administration
b. Joint Commission on Accreditation of Healthcare Organizations
c. National Institutes of Health
d. Centers for Disease Control and Prevention
ANSWER: a
FEEDBACK: a. Correct. The most important areas of hospital pharmacy compounding are
regulated by the Food and Drug Administration. These areas include poor
compounding practices, lack of sterility assurance, non-patient-specific
compounded drugs that are not for emergency use, routine and large amounts of
non-patient-specific compounded drugs, interstate distribution of large amounts of
the same, and lack of procedures to obtain these same drugs from outsourcing
facilities.
b. Incorrect. The most important areas of hospital pharmacy compounding are
regulated by the Food and Drug Administration. These areas include poor
compounding practices, lack of sterility assurance, non-patient-specific
compounded drugs that are not for emergency use, routine and large amounts of
non-patient-specific compounded drugs, interstate distribution of large amounts of
the same, and lack of procedures to obtain these same drugs from outsourcing
facilities.
c. Incorrect. The most important areas of hospital pharmacy compounding are
regulated by the Food and Drug Administration. These areas include poor
compounding practices, lack of sterility assurance, non-patient-specific
compounded drugs that are not for emergency use, routine and large amounts of
non-patient-specific compounded drugs, interstate distribution of large amounts of
the same, and lack of procedures to obtain these same drugs from outsourcing
facilities.
d. Incorrect. The most important areas of hospital pharmacy compounding are
regulated by the Food and Drug Administration. These areas include poor
compounding practices, lack of sterility assurance, non-patient-specific
compounded drugs that are not for emergency use, routine and large amounts of
non-patient-specific compounded drugs, interstate distribution of large amounts of
the same, and lack of procedures to obtain these same drugs from outsourcing
facilities.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.5 - Identify the most important areas of hospital pharmacy compounding that are regulated
by the Food and Drug Administration (FDA).
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:08 AM
DATE MODIFIED: 4/4/2023 11:59 PM
7. Which classification of sterile compounding is compounded in an ISO 5 primary engineering control?
a. Category 3
b. Category 2
c. Category 1
d. Hazardous sterile product
ANSWER: c
Copyright Cengage Learning. Powered by Cognero. Page 4
,Name: Class: Date:
Ch 01 Introduction
FEEDBACK: a. Incorrect. The Category 1 classification of sterile compounding is compounded in
an ISO 5 primary engineering control, such as a laminar-airflow workstation,
located in an unclassified segregated compounding area.
b. Incorrect. The Category 1 classification of sterile compounding is compounded in
an ISO 5 primary engineering control, such as a laminar-airflow workstation,
located in an unclassified segregated compounding area.
c. Correct. The Category 1 classification of sterile compounding is compounded in
an ISO 5 primary engineering control, such as a laminar-airflow workstation,
located in an unclassified segregated compounding area.
d. Incorrect. The Category 1 classification of sterile compounding is compounded in
an ISO 5 primary engineering control, such as a laminar-airflow workstation,
located in an unclassified segregated compounding area.
POINTS: 2
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.4 - Summarize the three classifications of compounded sterile preparations.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:10 AM
DATE MODIFIED: 4/5/2023 12:08 AM
8. To practice nuclear pharmacy, which of the following is an area in which a pharmacist must have specialized training?
a. Radiochemistry
b. Radiolabeling
c. Chemical integrity
d. Physical integrity
ANSWER: a
FEEDBACK: a. Correct. To practice nuclear pharmacy, radiochemistry is an area in which a
pharmacist must have specialized training. Other areas include nuclear physics,
radiation detection instrumentation, and radiation protection.
b. Incorrect. To practice nuclear pharmacy, radiochemistry is an area in which a
pharmacist must have specialized training. Other areas include nuclear physics,
radiation detection instrumentation, and radiation protection.
c. Incorrect. To practice nuclear pharmacy, radiochemistry is an area in which a
pharmacist must have specialized training. Other areas include nuclear physics,
radiation detection instrumentation, and radiation protection.
d. Incorrect. To practice nuclear pharmacy, radiochemistry is an area in which a
pharmacist must have specialized training. Other areas include nuclear physics,
radiation detection instrumentation, and radiation protection.
POINTS: 1
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.7 - Explain the training requirements to practice nuclear pharmacy.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:12 AM
DATE MODIFIED: 4/5/2023 12:09 AM
9. Which of the following types of radiation released by radionuclides is the most penetrating type?
Copyright Cengage Learning. Powered by Cognero. Page 5
,Name: Class: Date:
Ch 01 Introduction
a. Delta
b. Alpha
c. Gamma
d. Beta
ANSWER: c
FEEDBACK: a. Incorrect. The most penetrating type of radiation released by a radionuclide is
gamma radiation. It differs from alpha and beta radiation because it is
electromagnetic, while they are particulate.
b. Incorrect. The most penetrating type of radiation released by a radionuclide is
gamma radiation. It differs from alpha and beta radiation because it is
electromagnetic, while they are particulate.
c. Correct. The most penetrating type of radiation released by a radionuclide is
gamma radiation. It differs from alpha and beta radiation because it is
electromagnetic, while they are particulate.
d. Incorrect. The most penetrating type of radiation released by a radionuclide is
gamma radiation. It differs from alpha and beta radiation because it is
electromagnetic, while they are particulate.
POINTS: 3
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.6 - Identify how most radiopharmaceuticals are prepared.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:14 AM
DATE MODIFIED: 4/5/2023 12:10 AM
10. Technetium compounds are available in which of the following forms?
a. Iodine-131
b. Reagent kits
c. Cardioplegia solutions
d. Calcium phosphate precipitates
ANSWER: b
FEEDBACK: a. Incorrect. Technetium compounds are available in reagent kits, which contain the
particular compounds, usually in freeze-dried form. They are multidose vials that
contain the compound (ligand) as it is labeled.
b. Correct. Technetium compounds are available in reagent kits, which contain the
particular compounds, usually in freeze-dried form. They are multidose vials that
contain the compound (ligand) as it is labeled.
c. Incorrect. Technetium compounds are available in reagent kits, which contain the
particular compounds, usually in freeze-dried form. They are multidose vials that
contain the compound (ligand) as it is labeled.
d. Incorrect. Technetium compounds are available in reagent kits, which contain the
particular compounds, usually in freeze-dried form. They are multidose vials that
contain the compound (ligand) as it is labeled.
POINTS: 2
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
Copyright Cengage Learning. Powered by Cognero. Page 6
,Name: Class: Date:
Ch 01 Introduction
LEARNING OBJECTIVES: 1.6 - Identify how most radiopharmaceuticals are prepared.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:15 AM
DATE MODIFIED: 4/5/2023 12:11 AM
11. What are radiopharmaceuticals prepared to be used as?
a. Components of X-rays, ultraviolet rays, and visible light
b. IV admixtures used in centralized pharmacy facilities
c. Components to be administered within four hours
d. Tracers, for assessing the structure, function, secretion, excretion, and volume of an organ or tissue
ANSWER: d
FEEDBACK: a. Incorrect. Radiopharmaceuticals are prepared to be used as tracers, for
assessing the structure, function, secretion, excretion, and volume of an organ or
tissue. They are also used to analyze biological specimens, treat specific
diseases such as thyroid cancer and polycythemia vera, and to relieve bone pain.
b. Incorrect. Radiopharmaceuticals are prepared to be used as tracers, for
assessing the structure, function, secretion, excretion, and volume of an organ or
tissue. They are also used to analyze biological specimens, treat specific
diseases such as thyroid cancer and polycythemia vera, and to relieve bone pain.
c. Incorrect. Radiopharmaceuticals are prepared to be used as tracers, for
assessing the structure, function, secretion, excretion, and volume of an organ or
tissue. They are also used to analyze biological specimens, treat specific
diseases such as thyroid cancer and polycythemia vera, and to relieve bone pain.
d. Correct. Radiopharmaceuticals are prepared to be used as tracers, for assessing
the structure, function, secretion, excretion, and volume of an organ or tissue.
They are also used to analyze biological specimens, treat specific diseases such
as thyroid cancer and polycythemia vera, and to relieve bone pain.
POINTS: 2
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.6 - Identify how most radiopharmaceuticals are prepared.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:17 AM
DATE MODIFIED: 4/5/2023 12:12 AM
12. Which of the following is NOT a location in which radiopharmaceuticals are prepared?
a. In nuclear medicine departments
b. In community compounding pharmacies
c. In manufacturing sites, in their final form
d. In nuclear pharmacies
ANSWER: b
FEEDBACK: a. Incorrect. Radiopharmaceuticals are not prepared in community compounding
pharmacies. They may be prepared in their final form at manufacturing sites,
while others are compounded in nuclear pharmacies or nuclear medicine
departments.
b. Correct. Radiopharmaceuticals are not prepared in community compounding
pharmacies. They may be prepared in their final form at manufacturing sites,
Copyright Cengage Learning. Powered by Cognero. Page 7
, Name: Class: Date:
Ch 01 Introduction
while others are compounded in nuclear pharmacies or nuclear medicine
departments.
c. Incorrect. Radiopharmaceuticals are not prepared in community compounding
pharmacies. They may be prepared in their final form at manufacturing sites,
while others are compounded in nuclear pharmacies or nuclear medicine
departments.
d. Incorrect. Radiopharmaceuticals are not prepared in community compounding
pharmacies. They may be prepared in their final form at manufacturing sites,
while others are compounded in nuclear pharmacies or nuclear medicine
departments.
POINTS: 2
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.6 - Identify how most radiopharmaceuticals are prepared.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:19 AM
DATE MODIFIED: 4/5/2023 12:13 AM
13. Why do ISO Class 7 buffer areas and ISO Class 8 ante rooms use positive pressure?
a. So that there is nutritive media support growth of microorganisms
b. To allow colonies of one microorganism to reveal certain characteristics
c. Because positive pressure ensures that in the case of a breached barrier, the space remains sterile
d. So that the relative humidity rating does not exceed 60%
ANSWER: c
FEEDBACK: a. Incorrect. ISO Class 7 buffer areas and ISO Class 8 ante rooms use positive
pressure because it ensures that in the case of a breached barrier, the space
remains sterile.
b. Incorrect. ISO Class 7 buffer areas and ISO Class 8 ante rooms use positive
pressure because it ensures that in the case of a breached barrier, the space
remains sterile.
c. Correct. ISO Class 7 buffer areas and ISO Class 8 ante rooms use positive
pressure because it ensures that in the case of a breached barrier, the space
remains sterile.
d. Incorrect. ISO Class 7 buffer areas and ISO Class 8 ante rooms use positive
pressure because it ensures that in the case of a breached barrier, the space
remains sterile.
POINTS: 2
QUESTION TYPE: Multiple Choice
HAS VARIABLES: False
LEARNING OBJECTIVES: 1.10 - Explain which sterile compounding areas use positive pressure and negative pressure.
KEYWORDS: BLOOM'S LEVEL: Understand
DATE CREATED: 3/17/2023 2:20 AM
DATE MODIFIED: 4/5/2023 12:14 AM
14. Which of the following statements is true about preparing radiopharmaceuticals?
a. Masks and latex gloves are required
Copyright Cengage Learning. Powered by Cognero. Page 8